Pharmacology
ChanTest to Highlight its World-Leading Ion Channel Safety Services and Largest Catalog of Ion Channel-Expressing Cell Lines at Safety Pharmacology Society, Booth 702
Published in Medical Letter on the CDC and FDA, October 5th, 2008
ChanTest, the leading CRO provider of ion channel testing services for drug-discovery and development, will feature the latest in its expanding line of services in booth 702 at the Safety Pharmacology Society conference September 23-24, in Madison, Wisconsin. New FDA Critical Path safety profiling tools include the Cardiac, CNS, CVS, and Respiratory System Channel Panels(TM) designed to complement the FDA and ICH S7A and S7B safety guidances. Therapeutic panels include Pain/Inflammation and Epilepsy Channel Panels.
According to Dr. Arthur (Buzz) Brown, ChanTest's founder and CEO, ChanTest has validated the panels against the "gold standard" manual patch clamp to ensure...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- CV Technologies Inc.
Colds and flu cut by one-third in study of Canada's top cold fighter in vaccinated seniors - JAMA and Archives Journals
Higher urinary levels of commonly used chemical, BPA, linked with cardiovascular disease, diabetes - American Chemistry Council
New Bisphenol a Study Has Limited Capability to Assess Human Health Effects - BioSante Pharmaceuticals, Inc.
Let's Get It On - Cancer Gene Therapy
Epeius Biotechnologies' Lead Product, Rexin-G for Metastatic Cancer, Aptly Highlighted by National Cancer Institute Journal - Life Sciences
New life sciences research from S.V. Rao et al outlined - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
